Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment
ICD-10 E09.354 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment.
E09.354 refers to diabetes mellitus that is induced by drugs or chemicals, leading to significant complications such as proliferative diabetic retinopathy (PDR). PDR is characterized by the growth of new blood vessels in the retina, which can lead to serious vision problems. In this specific case, the patient experiences both traction retinal detachment and rhegmatogenous retinal detachment, conditions where the retina is pulled away from its normal position and where a tear in the retina allows fluid to accumulate, respectively. These complications are often a result of prolonged hyperglycemia and poor glycemic control, which can be exacerbated by the use of certain medications. Management of this condition requires careful monitoring of HbA1c levels, typically aiming for a target of less than 7% to minimize complications. Insulin therapy may be necessary to achieve optimal glycemic control, particularly in cases where oral hypoglycemics are ineffective due to the drug-induced nature of the diabetes. Regular ophthalmologic evaluations are crucial for early detection and management of retinopathy and retinal detachment.
Comprehensive medication history, HbA1c levels, and treatment plans.
Management of drug-induced diabetes, insulin therapy adjustments.
Ensure clear documentation of the drug or chemical causing diabetes.
Detailed retinal examination findings, imaging results, and treatment plans.
Evaluation and treatment of proliferative diabetic retinopathy and retinal detachment.
Document the type of retinal detachment and its relation to diabetic complications.
Used for treatment of proliferative diabetic retinopathy.
Document the extent of retinopathy and treatment plan.
Ophthalmology must document the rationale for the procedure.
Certain medications, including corticosteroids, antipsychotics, and some antihypertensives, can induce diabetes by affecting insulin sensitivity or secretion.
Diagnosis is typically made through a comprehensive eye examination, including fundus photography and fluorescein angiography, to assess for neovascularization and retinal detachment.
